Results 81 to 90 of about 51,447 (275)

A quality assurance phantom for electronic portal imaging devices [PDF]

open access: yes, 2011
Electronic portal imaging device (EPID) plays an important role in radiation therapy portal imaging, geometric and dosimetric verification. Consistent image quality and stable radiation response is necessary for proper utilization that requires routine ...
Cao, Minsong   +6 more
core   +1 more source

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi   +2 more
wiley   +1 more source

IMRT QA using machine learning: A multi-institutional validation. [PDF]

open access: yes, 2017
PurposeTo validate a machine learning approach to Virtual intensity-modulated radiation therapy (IMRT) quality assurance (QA) for accurately predicting gamma passing rates using different measurement approaches at different institutions.MethodsA Virtual ...
Chan, Maria F   +5 more
core   +2 more sources

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló   +5 more
wiley   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić   +4 more
wiley   +1 more source

Physical dosimetry of volumetric modulated arc therapy (VMAT) using EPID and 2D array for quality assurance

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2018
Outline: To address the correspondence of measured and predicted doses for different malignant tumours utilizing various gamma criteria and QA for confirmation of VMAT with an EPID and 2D array detector.
Ismail E. Mohamed   +4 more
doaj   +1 more source

Creating A Dynamic, Multi-Purpose Correction for Multiple Geometries and Field Sizes to Account for Off-Axis and Asymmetric Backscatter With Varian Portal Dosimetry

open access: yes, 2016
Intensity modulated radiation therapy and volumetric modulated arc therapy are increasingly common in radiation therapy due to their benefits of target conformity and normal tissue sparing.
Manigold, Remy
core   +1 more source

Validation and clinical implementation of an accurate Monte Carlo code for pencil beam scanning proton therapy. [PDF]

open access: yes, 2018
Monte Carlo (MC)-based dose calculations are generally superior to analytical dose calculations (ADC) in modeling the dose distribution for proton pencil beam scanning (PBS) treatments.
Ainsley, Christopher   +7 more
core   +2 more sources

Feasibility of Monte Carlo-based patient-specific quality assurance in 1.5 Tesla magnetic resonance-guided online adaptive radiotherapy: a multi-institutional study

open access: yesPhysics and Imaging in Radiation Oncology
Introduction: To evaluate the feasibility of Monte Carlo (MC)-based patient-specific quality assurance (PSQA) for MR-guided online adaptive radiotherapy and to explore the potential to eliminate the post-delivery measurement-based PSQA.
Ruiqi Li   +6 more
doaj   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Home - About - Disclaimer - Privacy